Back to search

Georgia Institute of Technology

Continuous manufacturing of beta-lactam antibiotics by enzymatic reactive crystallization

Abstract

dc:description.abstract

The enzymatic production of beta-lactam antibiotics can be simplified by integrating the synthesis and separation of the antibiotic within a single vessel. In situ crystallization during the synthesis of beta-lactam antibiotics improves yields by protecting the antibiotic, an intermediate in the enzyme catalyzed reaction pathway, from degradation by the enzyme. The design of a continuous synthesis, crystallization, and isolation (CSCI) process follows naturally because the reaction and crystallization kinetics are already coupled in the batch process. Rather than individually design and size several unit operations for use in series, a single unit that performs several operations at once was developed. The benefits of continuous reactive crystallization include simplified process control, improved environmental sustainability, and increased process performance. Enzyme catalysis decreases process mass intensity and increases reaction selectivity compared to chemical routes to beta-lactams. Use of process analytical technology (PAT) enables real time monitoring of critical process parameters (CPPs) to ensure production of pharmaceutical quality material. The kinetics of the enzyme reactions and antibiotic crystallization were determined in batch for ampicillin and cephalexin. A model of reactive crystallization was built and used to determine the optimal process configuration for continuous production of amoxicillin and cephalexin. Finally, implementation of the continuous process in the lab was begun. This process will enable more sustainable production of beta-lactam antibiotics with potential for on-demand production, especially important in light of recent drug shortages due to the 2020 SARS-CoV-2 pandemic.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Chemical and Biomolecular Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Mcdonald, Matthew Alexander
Advisors dc:contributor.advisor
  • Rousseau, Ronald W.
  • Grover, Martha A.
  • Bommarius, Andreas S.
Committee members dc:contributor.committeemember
  • Brettmann, Blair K
  • Lieberman, Raquel L

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/64110

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Mcdonald, Matthew Alexander. Continuous manufacturing of beta-lactam antibiotics by enzymatic reactive crystallization. Doctoral thesis, Georgia Institute of Technology, 2020. http://hdl.handle.net/1853/64110